Berylson Capital Partners’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Berylson Capital Partners’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,720	Closed	-$2.85M	–	37
2019 Q4	$2.85M	Buy	20,720 +8,585	+71%	+$1.04M	2.41%	23
2019 Q3	$1.44M	Hold	12,135	–	–	3.63%	15
2019 Q2	$1.7M	Hold	12,135	–	–	3.05%	16
2019 Q1	$2.17M	Buy	+12,135	New	+$1.82M	2.57%	18

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Berylson Capital Partners's ORTX Position: Q1 2020 in Review

Berylson Capital Partners sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2020, closing a stake of 20,720 shares — an estimated $2.85M sold.

Berylson Capital Partners first reported a position in ORTX in Q1 2019 and held it in 4 quarters. The position peaked at $2.85M in Q4 2019. 74 funds tracked by Wall St. Rank hold ORTX as of Q1 2020.

Berylson Capital Partners reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
Berylson Capital Partners sold 20,720 Orchard Therapeutics plc American Depositary Shares shares in Q1 2020, an estimated $2.85M.
Berylson Capital Partners first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2019 and held it in 4 quarters.
Berylson Capital Partners's Orchard Therapeutics plc American Depositary Shares position peaked at $2.85M in Q4 2019.
74 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2020.

Based on Berylson Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.